Sentences with phrase «no a cancer cell»

Instead of being injected into the bloodstream and exposed to the rest of the body's tissue — with all the unpleasant side effects, as is the case with chemotherapy — these agents only target cancer cells.

A series of preliminary Mayo Clinic studies conducted in 2010 showed promise for the potential use of a chemical component of green tea (epigallocatechin gallate) in reducing the number of cancer cells in patients with chronic lymphocytic leukemia.

Weeks later, Yee realized that he didn't have the equipment he needed to pluck out of Ziskin's blood the rare (perhaps one in 100,000) T cells that could identify the subtle peptide markers on the surface of her cancer cells and attack the disease.

This feat is possible because cancer cells emit a different kind of metabolic waste than healthy cells.

The medicines, which help unleash the immune system on cancer cells, were tested in patients with advanced lung cancer.

When placed at the site of a cancerous tumour in a rodent and «activated» by a scope with a light source, the compounds eradicated up to 100 % of cancer cells.

Chemotherapy works by killing cancer cells by targeting fast - dividing cells, and in most cases, kills off some healthy cells along the way, including nerve cells in the brain.

The cancerous cells win out over the healthy blood cells in the bone marrow, which in turn leads to kidney problems when the cancer cells make abnormal proteins instead of antibodies.

IFM has two preclinical programs, which work to enhance the immune system's response to cancer cells.

That company is pioneering medical uses for carbon molecules called nanospheres, such as attacking cancer cells and dramatically improving magnetic - resonance - imaging contrasts.

The Parker Institute for Cancer Immunotherapy will focus on the emerging field of cancer immunotherapy, which harnesses the body's immune system to fight cancer cells.

Gilead subsidiary Kite Pharma (which the biotech giant scooped up ahead of the FDA's approval for Yescarta, a treatment that reengineers patients» immune cells to fight cancer) will have access to Sangamo's platform technology, which could be used to create various types of cancer cell therapies.

In contrast, the typical, less efficient method of treating cancer uses combinations of surgery, chemotherapy and radiation to kill cancer cells.

A veteran of digital imaging technology, in 1999 he founded Quantitative Imaging Corp. (QImaging), a manufacturer of digital cameras for scientific and industrial uses — the kind, for example, that can detect microscopic, early - stage cancer cells.

The Napster founder and former Facebook president created the Parker Institute for Cancer Immunotherapy, which will focus on using the body's immune system to combat cancer cells.

Then the cells are taken to Novartis» manufacturing facility in New Jersey, at which point the cells are reengineered to recognize cancer cells and wipe them out.

It's a type of cancer immunotherapy, which harnesses the body's immune system to take on cancer cells.

We are teaching the T cells, the lymphocytes, multiple cells to be more proactive in cleaning up the cancer cells in the brain.

JCAR017 uses a defined CD4: CD8 cell composition and 4 - 1BB as the co-stimulatory signaling domain to mimic a «second signal» that amplifies the activation of CAR T cells, which according to Juno leads to a more robust signal to the T cell to multiply and kill the cancer cell.

The company leverages its unique insights in cancer biology and the immune system to discover and develop novel oral small molecules that activate immune responses to eliminate cancer cells.

Acquiring high - definition images of every cancer cell found in a blood sample, making characterization at single - cell resolution possible.

Its drug Niraparib kills cancer cells by inhibiting the production of proteins called PARPs, which help repair damaged DNA strands, thereby hastening the death of some types of cancer cells.

Tesaro has a coveted position as a leader in the so - called immuno - oncology sector, which harnesses the body's own immune system to combat cancer cells.

Immune oncology drugs use a mechanism to enable the immune system to «uncloak» hidden cancer cells in the body and then attack them.

Cambridge, MA — February 6, 2017 — Aura Biosciences, a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells using viral nanoparticle conjugates, announced today that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug application (IND) for the company's lead program, light - activated AU - 011 in ocular melanoma (OM).

Cambridge, MA — December 21, 2017 — Aura Biosciences, a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells using viral nanoparticle conjugates, announced today that it closed a $ 30 million Series C financing.

Cambridge, MA — March 30, 2017 — Aura Biosciences, a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells using viral nanoparticle conjugates, announced today that it has enrolled and dosed the first patient in its Phase 1b clinical trial of light - activated AU - 011, an investigational, first - in - class targeted therapy in development for the treatment of ocular melanoma, a rare and life - threatening disease.

Investigators have repeatedly touted the drug as a potential lynchpin in immuno - oncology, focusing on an enzyme that suppresses the immune cells Opdivo and a whole new class of PD - 1 / L1 checkpoints are designed to unleash in an attack on cancer cells.

These nanobots are built to detect cancer cells in the human body and apply treatment directly to them.

CAR - T approaches involve reengineering T - cells to find and destroy cancer cells, but that process can cause cytokine release syndrome (CRS), a life - threatening immune response NantKwest hopes to sidestep.

A 17 - year - old California girl won $ 100,000 in a national science competition for her creation of a nanoparticle that can target and kill cancer cells.

It's only been tested on mice so far, but the results are tremendously promising for an antibody Stanford researchers have been experimenting with that blocks the body from «eating» cancer cells.

This makes me happy: Microglia cells migrate into tumors and supply cancer cells with a substance needed for the repair of DNA damage.

... In lung cancer cell lines, CBD upregulated ICAM - 1, leading to...

All living beings, including cancer cells, do this to one degree or another; hence all living beings have intrinsic value.

Thus, in choosing between a cancer cell in a woman and the woman herself, the cancer cell can be sacrificed.

Her doctor suggested Erbitux — a proven cancer drug that targets cancer cells exclusively, unlike conventional chemotherapies that more crudely kill all fast - growing cells in the body — and Aucoin went to a clinic to begin treatment.

We have no more final answers for the flowering of evil than we do for the multiplying of cancer cells.

People throw their crutches away; the cancer cells miraculously disperse; life is prolonged.

Before somebody comes along and says the same thing about a cancer cell, the big caveat is that if its a part of the body that is hurting you, then it should go.

Also, why do cancer cells transplanted into healthy organs often not develop into tumours.

For example, cancer cells tend to use glycolysis in the cell cytoplasm in their metabolism, an ancient system, whereas healthy cells use oxidation - phosphorylation.

Once started, cancer cells show accelerated growth, mobility, spread and colonisation.

Darwinian evolution suggests that cancer cells result from random mutations, surviving the attacks by the body's antibodies, etc..

Elsewhere, Philip Ball, an English science writer, reports on research into the mechanical properties of cancer cells.

There is evidence to suggest that cancer cells are softer than normal cells (although tumours are stiffer).

This could offer a technique to help in the prognosis of metastases, the spreading of cancer cells to other regions of the body, responsible for 90 per cent of deaths from cancer.

Metastasis involves clumps of cancer cells becoming detached and moving through the blood stream or the lymphatic system to other areas, where they become attached to a new site and continue growing.

Cancer cells, in contrast, continue to live and multiply instead of dying when they should; they behave in a purely selfish way (I sometimes joke that this is rather like some students — a joke that is not always appreciated).

A fascinating article by the polymath British theoretical physicist Professor Paul Davies considers the evolutionary characteristics of cancer cells.